Integral Diagnostics Ltd
ASX:IDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Integral Diagnostics Ltd
ASX:IDX
|
AU |
|
Network International Holdings PLC
LSE:NETW
|
AE |
|
Oriental Payment Group Holdings Ltd
HKEX:8613
|
HK |
|
M
|
Mcnulty Korea Co Ltd
KOSDAQ:222980
|
KR |
|
Cosco Shipping International (Singapore) Co Ltd
SGX:F83
|
SG |
|
Andromeda Metals Ltd
ASX:ADN
|
AU |
|
Celsius Holdings Inc
NASDAQ:CELH
|
US |
|
Interparfums SA
PAR:ITP
|
FR |
|
Lectra SA
PAR:LSS
|
FR |
|
P
|
Philomaxcap AG
F:HBD1
|
DE |
|
L
|
Lygend Resources & Technology Co Ltd
HKEX:2245
|
CN |
Wall Street
Price Targets
IDX Price Targets Summary
Integral Diagnostics Ltd
According to Wall Street analysts, the average 1-year price target for
IDX
is 3.24 AUD
with a low forecast of 2.06 AUD and a high forecast of 4.14 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IDX's stock price target?
Price Target
3.24
AUD
According to Wall Street analysts, the average 1-year price target for
IDX
is 3.24 AUD
with a low forecast of 2.06 AUD and a high forecast of 4.14 AUD.
What is Integral Diagnostics Ltd's Revenue forecast?
Projected CAGR
13%
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's revenue is
24%.
The projected
CAGR
for the next 3 years is
13%.
What is Integral Diagnostics Ltd's Operating Income forecast?
Projected CAGR
28%
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's operating income is
17%.
The projected
CAGR
for the next 3 years is
28%.
What is Integral Diagnostics Ltd's Net Income forecast?
Projected CAGR
143%
For the last 11 years the
compound annual growth rate for
Integral Diagnostics Ltd's net income is
-2%.
The projected
CAGR
for the next 3 years is
143%.
